Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What CAGR Is Anticipated for the Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Through 2029?
The market size for polymerase chain reaction (PCR) testing for sexually transmitted infections (STI) and vaginitis has seen a fast-paced growth in the past few years. The market, which was valued at $0.62 billion in 2024, is predicted to reach $0.68 billion in 2025, showcasing a compound annual growth rate (CAGR) of 10.1%. Various factors have contributed to this growth during the historical period, including the expansion of telemedicine platforms, the wide adoption of electronic health records, increased insurance coverage, the implementation of community-based testing initiatives, and the growing count of diagnostic tests.
In the coming years, the market size for sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing is set to witness robust growth. The estimated growth will see the market valuation soar to approximately $0.99 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.8%. Factors like the worldwide increase in sexually transmitted infections, a growing number of vaginal infection cases, the rise in individuals in their reproductive age, and global population growth are contributing to the growth predicted for this period. In the meantime, major trends to observe include technological advancements, the embracing of multiplex PCR panels, integration with telehealth and digital devices, and the emergence of self-testing kits.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27412&type=smp
What Market Forces Are Driving The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Sector In 2025 And Beyond?
The growth of STI and vaginitis PCR testing market is expected to surge due to increasing sexual health screenings. These screenings are medical tests aimed at detecting sexually transmitted infections and other related conditions early enough for treatment and disease spread prevention. A global uptick in sexually transmitted infections has necessitated such screenings, enabling early detection, prompt treatment and therefore cutting short potential complications and infection spread. These screenings are vital in STI and vaginitis PCR testing as they allow for early and accurate identification of various infections, often pre-symptomatic, thus enabling immediate treatment and prevention of complications and infection spread. To illustrate, the UK Health Security Agency reported that in June 2023, a total of 2,195,909 sexual health screening services for chlamydia, gonorrhea, syphilis, or HIV were conducted, showing a 13.4% increase from 1,936,455 tests done in 2021. Consequently, it’s evident that the rise in sexual health screenings is contributing to the sexually transmitted infection and vaginitis PCR testing market growth.
How Is The Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Categorized By Segments?
The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market covered in this report is segmented
1) By Test Type: Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels, Vaginitis Polymerase Chain Reaction (PCR) Panels
2) By Condition: Sexually Transmitted Infections, Vaginal Infections
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Homecare Or At-Home Testing, Other End Users
Subsegments:
1) By Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels: Chlamydia Trachomatis Polymerase Chain Reaction, Neisseria Gonorrhoeae Polymerase Chain Reaction, Trichomonas Vaginalis Polymerase Chain Reaction, Herpes Simplex Virus Polymerase Chain Reaction, Human Papillomavirus Polymerase Chain Reaction, Mycoplasma Genitalium Polymerase Chain Reaction, Syphilis Polymerase Chain Reaction, Multiplex Sexually Transmitted Infection Polymerase Chain Reaction Panels
2) By Vaginitis Polymerase Chain Reaction (PCR) Panels: Bacterial Vaginosis Polymerase Chain Reaction, Candida Species Polymerase Chain Reaction, Trichomoniasis Polymerase Chain Reaction, Mixed Vaginitis Polymerase Chain Reaction Panels, Aerobic Vaginitis Polymerase Chain Reaction, Atrophic Vaginitis Polymerase Chain Reaction
What Long-Term Trends Are Likely To Affect The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market?
Leading firms in the STI and vaginitis PCR testing market are concentrating on creating unique solutions, like multiplex PCR tests, to enhance diagnostic precision, diminish test duration, and expedite treatment choices. The term Multiplex PCR tests apply to the diagnostic procedures that can identify several pathogens concurrently from a single sample via one PCR procedure. For example, Cepheid Inc., a molecular diagnostics firm from the US, launched the Xpert Xpress Multiplex Vaginal Panel (MVP) in November 2022. This is a quick multiplex PCR test engineered to identify DNA from the top three sources of vaginal infections, namely bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis, utilizing just one vaginal sample. Delivering results within an estimated 60 minutes, this test enables a quicker and more accurate diagnosis in women showing symptoms, assisting in targeted treatments that aim to reduce treatment failures and unnecessary use of antibiotics. When used in conjunction with Cepheid’s GeneXpert systems, it enhances clinical decision-making and patient results by rapidly recognizing co-infections at the point of care.
Which Firms Are Considered Leaders In The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Space?
Major companies operating in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Hologic Inc., QIAGEN N.V., ARUP Laboratories Inc., Seegene Inc., LetsGetChecked Ltd., Sansure Biotech Inc., Visby Medical Inc., R-Biopharm AG, Savyon Diagnostics Ltd., altona Diagnostics GmbH, SpeeDx Pty Ltd., CERTEST BIOTEC S.L., ALPCO Diagnostics, Atila Biosystems Inc., Ridacom Diagnostics Ltd., Sinochips Diagnostics Co Ltd., Vitassay S.L., and Bioperfectus Technologies Co. Ltd.
Get The Full Report Here:
What Role Do Regional Policies And Investments Play In Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Expansion?
North America was the largest region in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market in 2024. The regions covered in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27412&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model